Breast cancer in Brazil: Epidemiology and treatment challenges

Breast Cancer: Targets and Therapy

Volumn 7, Issue , 2015, Pages 43-49

  Cecilio, Adma Poliana ^a   Takakura, Erika Tomie ^a   Jumes, Jaqueline Janaina ^a   Dos Santos, Jeane Wilhelm ^a   Herrera, Ana Cristina ^b   Victorino, Vanessa Jacob ^c   Panis, Carolina ^a  

^a UNIVERSIDADE ESTADUAL DO OESTE DO PARANÁ   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Brazil; Breast cancer; Cancer screening; Epidemiology; Health policies; Mam mograms; Prevention; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; NAVELBINE; PACLITAXEL; TRASTUZUMAB;

AGE; ARTICLE; BRAZIL; BREAST CANCER; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SCREENING; CANCER STAGING; EARLY DIAGNOSIS; FAMILY HISTORY; GENE MUTATION; GEOGRAPHIC DISTRIBUTION; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE POLICY; HUMAN; LIFE EXPECTANCY; LIFESTYLE; MAMMOGRAPHY; OBESITY; PHASE 2 CLINICAL TRIAL (TOPIC); URBANIZATION;

EID: 84922153730     PISSN: None     EISSN: 11791314     Source Type: Journal    
DOI: 10.2147/BCTT.S50361     Document Type: Article

References (42)

1. Instituto Brasileiro de Geografa e Estatística (IBGE). Escassez e Fartura: Distribuição da Oferta de Equipamentos de Diagnóstico por Imagem no Brasil [Scarcity and abundance: distribution of supply diagnostic imaging equipment in Brazil]. Rio de Janeiro: IBGE; 2009 [cited February 14, 2013]. Available from: http://www.ibge.gov.br/home/estatistica/populacao/indic_sociosaude/2009/com_esca.pdf. Accessed August 2, 2014. Portuguese.
2. Ministério da Saúde. Secretaria Executiva. SUS: Princípios e Conquistas [SUS: Principles and Achievements]. Brasília: Ministério da Saúde; 2000. Available from: http://bvsms.saude.gov.br/bvs/publicacoes/sus_princip-ios.pdf. Accessed August 4, 2014. Portuguese.
3. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.
4. Lee BL, Liedke PE, Barrios CH, Simon SD, Finkelstein DM, Goss PE. Breast cancer in Brazil: present status and future goals. Lancet Oncol. 2012;13(3):e95–e102.
5. Azevedo G, Mendonça S. Cancer in the female population in Brazil. Rev Saude Publica. 1993;27(1):68–75. Portuguese.
6. Moraes MF. A mortalidade por câncer de mama no Brasil [Mortality from breast cancer in Brazil Revista Brasileira de Cancerologia. 1998;44:2. Portuguese.
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127(12):2893–2917.
8. DATASUS [database on the Internet]. Ministério da Saúde; 2008. Available from: http://www2.datasus.gov.br/DATASUS/index.php?area=01. Accessed July 28, 2014. Portuguese.
9. SISMAMA. Sistema de Informação do Controle do Câncer de Mama – manual gerencial [Information Systems for Control of Breast Cancer – Manual Management]. Equipe de Elaboração: Maria Beatriz Kneipp Dias. Rio de Janeiro: Brazillian Ministry of Health. Available from: http://www2.inca.gov.br/wps/wcm/connect/cancermama/site/ home/sismama. Accessed July 28, 2014. Portuguese.
10. Prata PR. A transição epidemiológica no Brasil [The epidemiologic transition in Brazil]. Cad Saude Publica. 1992;8:168–175. Portuguese.
11. Doll R. Are we winning the fight against cancer? An epidemiologi-cal assessment. EACR – Mühlbock memorial lecture. Eur J Cancer. 1990;26:500–508.
12. Herrera AC, Panis C, Victorino VJ, et al. Molecular subtype is determinant on inflammatory status and immunological profle from invasive breast cancer patients. Cancer Immunol Immunother. 2012;61: 2193–2201.
13. Panis C, Victorino VJ, Herrera AC, et al. Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer. Breast Cancer Res Treat. 2012;133:881–888.
14. Panis C, Lemos LG, Victorino VJ, et al. Immunological effects of taxol and adryamicin in breast cancer patients. Cancer Immunol Immunother. 2012;61:481–488.
15. Panis C, Herrera AC, Victorino VJ, et al. Oxidative stress and hematologi-cal profiles of advanced breast cancer patients subjected to paclitaxel or doxorubicin chemotherapy. Breast Cancer Res Treat. 2012;133: 89–97.
16. Panis C, Herrera AC, Victorino VJ, Aranome A, Cecchini R. Screening of circulating TGF-β levels and its clinicopathological signifcance in human breast cancer. Anticancer Res. 2013;33:737–742.
17. Adami HO, Hunter D, Trichopoulos D, editors. Textbook of Cancer Epidemiology. 2nd ed. Oxford: Oxford University Press; 2008.
18. Dufoth RM, Carvalho S, Heinrich JK, et al. Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history. Sao Paulo Med J. 2005;123(4):192–197.
19. Ewald IP, Izetti P, Vargas FR, et al. Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome. Hered Cancer Clin Pract. 2011;9:12.
20. Koifman S, Koifman RJ. Environment and cancer in Brazil: an overview from a public health perspective. Mutat Res. 2003;544(2–3): 305–311.
21. Richards MA, Smith P, Ramirez AJ, Fentiman IS, Rubens RD. The infuence on survival of delay in the presentation and treatment of symptomatic breast cancer. Br J Cancer. 1999;79:858–864.
22. Simon SD, Bines J, Barrios CH, et al. Clinical characteristics and outcome of treatment of Brazilian women with breast cancer treated at public and private institutions – the AMAZONE project of the Brazilian breast cancer study group (GBECAM). Abstracts of the 2009 CTRC-AACR San Antonio Breast Cancer Symposium; December 9–13, 2009; San Antonio, TX. Suppl to volume 69, Issue 24 of Cancer Research.
23. Instituto Nacional de Câncer. Controle do Câncer de Mama: fatores de risco [Breast cancer control: risk factors] [webpage on the Internet]. Rio de Janeiro: Ministério da Saúde. Available from: http://www2. inca.gov.br/wps/wcm/connect/acoes_programas/site/home/nobrasil/ programa_controle_cancer_mama/fatores_risco. Accessed July 28, 2014. Portuguese.
24. Lima-Costa MF, Matos DL. Prevalence and factors associated with mammograms in the 50–69-year age group: a study based on the Brazilian National Household Sample Survey (PNAD-2003). Cad Saude Publica. 2007;23:1665–1673. Portuguese.
25. Boyle P, Levin B, editors. World Cancer Report 2008. Lyon: International Agency for Research on Cancer; 2008. Available from: http://www.iarc.fr/en/publications/pdfs-online/wcr/2008/. Accessed August 15th, 2014.
26. Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011;12:387–398.
27. FIOCRUZ – Cobertura de mamografa – PROADESSII – Fiocruz, 2011. Available from: http://www.proadess.icict.fiocruz.br/index. php?pag=fc&cod=A07&tab=1. Accessed August 2, 2014. Portuguese.
28. Freitas RF, Rahal RMS, Rodrigues DCN. Dados sobre produção de mamografas no Brasil, em 2012 e 2013 e número de mamógrafos em uso em 2013 [Data regarding mammograms in Brazil, between 2012 and 2013, and the number of mammographs]. Fevereiro de 2014. Available from: http://www.sbmastologia.com.br/index/index.php/component/content/article/50-destaque-medico/321-dados-sobre-producao. Accessed July 28, 2014. Portuguese.
29. Portaria n.º 1101/GM [Ordinance No. 1101/GM]. Brasília: Ministério da Saúde; 2002. Available from: http://dtr2001.saude.gov.br/sas/POR-TARIAS/Port2002/Gm/GM-1101.htm. Accessed November 19, 2014. Portuguese.
30. Laurenti R. Transição demográfca e transição epidemiológica [Demographic and epidemiologic transition]. Anais do 1º Congresso Brasileiro de Epidemiologia; 1990 set 2–6; Campinas, Brasil. Rio de Janeiro: Abrasco; 1990:143–165. Portuguese.
31. Albala C, Vio F, Yanez M. Transición epidemiológica en América Latina: comparación de cuatro países [Epidemiological transition in Latin America: comparison of 4 countries]. Rev Med Chil. 1997;125(6):719– 727. Portuguese.
32. Baracat FF, de Lima GR, de Oliveira AB, Baracat F, Baracat F. Infammatory carcinoma of the breast. Experience of 43 cases at the Instituto do Câncer Arnaldo Vieira de Carvalho Rev Paul Med. 1988;106(1):14–20. Portuguese.
33. Schwartsmann G, Mans DR, Menke CH, et al. A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer. Oncology (Williston Park). 1997;11(4 Suppl 3):24–29.
34. Murad AM, Guimaraes RC, Amorim WC, Morici AC, Ferreira-Filho AF, Schwartsmann G. Phase II trial of the use of paclitaxel and gemcitabine as a salvage treatment in metastatic breast cancer. Breast Cancer Res Treat. 1997;45(1):47–53.
35. Murad AM, Guimarães RC, Aragão BC, Scalabrini’Neto AO, Rodrigues VH, Garcia R. Gemcitabine and paclitaxel as salvage therapy in metastatic breast cancer. Oncology (Williston Park). 2001; 15(2 Suppl 3):25–27.
36. Hegg R, Costa MA, Perdicaris M, et al. A phase II trial of fractionated vinorelbine/doxorubicin as frst line therapy for advanced breast cancer. Curr Med Res Opin. 2001;16(4):225–234.
37. Costa LJ, Varella PC, del Giglio A. Weight changes during chemotherapy for breast cancer. Sao Paulo Med J. 2002;120(4):113–117.
38. Anelli A, Brentani RR, Gadelha AP, Amorim De Albuquerque A, Soares F. Correlation of p53 status with outcome of neoadjuvant chemotherapy using paclitaxel and doxorubicin in stage IIIB breast cancer. Ann Oncol. 2003;14(3):428–432.
39. Piato JR, Barros AC, Pincerato KM, Sampaio AP, Pinotti JA. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur J Surg Oncol. 2003;29(2):118–120.
40. Gianni L, Pienkowski T, Im YH, et al. Efficacy and safety of neoad-juvant pertuzumab and trastuzumab in women with locally advanced, infammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial. Lancet Oncol. 2012;13(1):25–32.
41. Ministério da Saúde (Br). Secretaria de Atenção à Saúde. Controle dos Cânceres do Colo do Útero e da Mama [Control of breast and uterine cancers]. Brasília: Ministério da Saúde; 2014. Portuguese.
42. Ministério da Saúde (Br). Secretaria de Atenção à Saúde. Controle dos Cânceres do Colo do Útero e da Mama [Control of breast and uterine cancers]. Brasília: Ministério da Saúde; 2006. Portuguese.